Novo Nordisk A/S
NVO
$44.96
$0.571.28%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 82.05% | 3.89% | -22.10% | 39.35% | 10.71% |
| Total Depreciation and Amortization | 1.73% | 62.07% | 70.35% | 117.26% | 68.83% |
| Total Amortization of Deferred Charges | -- | 36.01% | -- | -- | -- |
| Total Other Non-Cash Items | -22.33% | -47.34% | 14.68% | -69.73% | 295.54% |
| Change in Net Operating Assets | -134.67% | 63.32% | 53.19% | -49.14% | -55.42% |
| Cash from Operations | 6.01% | -32.45% | 11.77% | -14.86% | 67.38% |
| Capital Expenditure | 8.27% | -24.83% | -19.54% | -47.62% | -53.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 101.34% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -105.86% | -533.91% | 78.26% | 104.54% | -41.99% |
| Cash from Investing | -113.23% | 48.81% | 21.56% | 27.55% | -246.42% |
| Total Debt Issued | -41.61% | -31.59% | 499.16% | 31.07% | -- |
| Total Debt Repaid | 89.76% | -166.28% | -115.41% | -1,183.53% | -3,695.58% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -72.91% | 100.00% | 100.00% | 100.00% | 51.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.97% | -- | -13.67% | -- | -19.67% |
| Other Financing Activities | -78.67% | -- | -- | -402.67% | 387.03% |
| Cash from Financing | -510.92% | -12.75% | 1.24% | -392.13% | 116.96% |
| Foreign Exchange rate Adjustments | -249.34% | -83.88% | 119.24% | -2,133.13% | -289.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.95% | 85.18% | 245.71% | -146.49% | 379.58% |